机译:菌根抗性,ALK阳性非小细胞肺癌中的疗效,安全性和生物标志物分析:多期,第2期试验
Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med Dept Med Oncol State Key Lab Oncol South China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Resp Dis Thorac Dis Ctr Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Resp Dis Thorac Dis Ctr Hangzhou Zhejiang;
Nanjing Med Univ Jiangsu Canc Hosp Jiangsu Inst Canc Res Dept Med Oncol Affiliated Canc Hosp;
Fujian Med Univ Fujian Prov Canc Hosp Dept Thorac Oncol Canc Hosp Fuzhou Fujian Peoples R;
Hunan Canc Hosp Dept Med Oncol Chest Changsha Hunan Peoples R China;
Beijing Canc Hosp Dept Thorac Oncol Beijing Peoples R China;
Chinese Acad Med Sci Peking Union Med Coll Hosp Peking Union Med Coll Dept Pulm Med Beijing;
Zhengzhou Univ Henan Prov Canc Hosp Resp Dept Internal Med Affiliated Canc Hosp Zhengzhou;
Zhejiang Canc Hosp Thorac Med Oncol Hangzhou Zhejiang Peoples R China;
Nanjing Univ Jinling Hosp Div Resp Med Sch Med Nanjing Jiangsu Peoples R China;
Chinese Peoples Liberat Army Gen Hosp Dept Oncol Beijing Peoples R China;
Qingdao Univ Dept Oncol Affiliated Hosp Qingdao Shandong Peoples R China;
Sichuan Univ West China Hosp Canc Ctr Dept Thorac Oncol Chengdu Sichuan Peoples R China;
Huazhong Univ Sci &
Technol Tongji Hosp Tongji Med Coll Dept Oncol Wuhan Hubei Peoples R China;
Xiamen Univ Affiliated Hosp 1 Fujian Med Univ Sch Med Dept Med Oncol Canc Hosp Teaching Hosp;
Capital Med Univ Beijing Chest Hosp Beijing TB &
Thorac Tumor Res Inst Dept Med Oncol Beijing;
Univ Sci &
Technol China Anhui Prov Hosp Resp Med Affiliated Hosp 1 Hefei Anhui Peoples R;
Zhejiang Canc Hosp Thorac Med Oncol Hangzhou Zhejiang Peoples R China;
Huazhong Univ Sci &
Technol Union Hosp Tongji Med Coll Canc Ctr Wuhan Hubei Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Pulm &
Crit Care Med Guangzhou Guangdong Peoples R China;
Guangzhou Med Univ Natl Clin Res Ctr Resp Dis Guangzhou Inst Resp Hlth Resp Med Dept Affiliated;
First Hosp Jilin Univ Canc Ctr Changchun Jilin Peoples R China;
Beijing Canc Hosp Dept Thorac Oncol Beijing Peoples R China;
First Peoples Hosp Foshan Dept Head &
Neck &
Thorac Med Oncol Foshan Peoples R China;
China Med Univ Oncol Med Hosp 1 Shenyang Liaoning Peoples R China;
Gen Hosp Northern Theater Command Oncol Dept Shenyang Liaoning Peoples R China;
Yunnan Canc Hosp Dept Thorac Surg 2 Kunming Yunnan Peoples R China;
Chinese Acad Med Sci Dept Diagnost Radiol Peking Union Med Coll Natl Canc Ctr Canc Hosp Natl;
Chinese Acad Med Sci Peking Union Med Coll Hosp Peking Union Med Coll Dept Radiol Beijing;
Chinese Peoples Liberat Army Gen Hosp Dept Pulm Oncol Med Ctr 5 Beijing Peoples R China;
Chinese Acad Med Sci Dept Diagnost Radiol Peking Union Med Coll Natl Canc Ctr Canc Hosp Natl;
Betta Pharmaceut Hangzhou Zhejiang Peoples R China;
Betta Pharmaceut Hangzhou Zhejiang Peoples R China;
X Covery Holdings Palm Beach Gardens FL USA;
Betta Pharmaceut Hangzhou Zhejiang Peoples R China;
Betta Pharmaceut Hangzhou Zhejiang Peoples R China;
Hangzhou Repugene Technol Hangzhou Zhejiang Peoples R China;
Hangzhou Repugene Technol Hangzhou Zhejiang Peoples R China;
Sun Yat Sen Univ Collaborat Innovat Ctr Canc Med Dept Med Oncol State Key Lab Oncol South China;
机译:菌根抗性,ALK阳性非小细胞肺癌中的疗效,安全性和生物标志物分析:多期,第2期试验
机译:Alectinib治疗ALK阳性,耐克唑替尼的非小细胞肺癌:单组,多中心,2期试验
机译:邻苯胺在屈尿层抗性ALK阳性非小细胞癌中的中枢神经系统转移中的疗效:RECIST 1.1和RANO-HGG标准的比较
机译:非小细胞肺癌生物标志物的数据分析与网络研究
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:艾乐替尼治疗ALK阳性耐克唑替尼的非小细胞肺癌的2期前瞻性分析
机译:MA07.02从ALK阳性非小细胞肺癌中的alectimib阶段的第2阶段NP28761研究的疗效和安全数据更新了疗效和安全数据